Yanling Li

941 total citations
44 papers, 639 citations indexed

About

Yanling Li is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Yanling Li has authored 44 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Cell Biology. Recurrent topics in Yanling Li's work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Yanling Li is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Yanling Li collaborates with scholars based in China, United States and Singapore. Yanling Li's co-authors include Qianjin Liao, Yanhong Zhou, Wentao Li, Lin Liang, Xin Li, Jianhong Lu, Shuyu Xin, Ying Lu, Wentao Li and Lin Liang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yanling Li

43 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanling Li China 17 395 168 91 79 57 44 639
Qingqing Wu China 16 473 1.2× 207 1.2× 97 1.1× 134 1.7× 46 0.8× 52 909
Shruti Rawal New Zealand 12 324 0.8× 201 1.2× 121 1.3× 63 0.8× 38 0.7× 21 714
Guoqiang Yuan China 14 268 0.7× 133 0.8× 44 0.5× 43 0.5× 58 1.0× 63 541
Yingying Xu China 15 517 1.3× 162 1.0× 54 0.6× 42 0.5× 75 1.3× 34 817
Sang‐Hyun Min South Korea 18 608 1.5× 94 0.6× 125 1.4× 148 1.9× 25 0.4× 48 880
Yulong Chen China 15 359 0.9× 184 1.1× 156 1.7× 104 1.3× 79 1.4× 60 749
Yan Hang United States 19 795 2.0× 87 0.5× 68 0.7× 83 1.1× 32 0.6× 27 1.7k
Jingjie Zhang China 15 468 1.2× 178 1.1× 59 0.6× 109 1.4× 198 3.5× 45 898
Jie Ruan China 13 252 0.6× 81 0.5× 124 1.4× 36 0.5× 26 0.5× 27 469
Yajie Zhu China 12 363 0.9× 183 1.1× 57 0.6× 57 0.7× 42 0.7× 31 534

Countries citing papers authored by Yanling Li

Since Specialization
Citations

This map shows the geographic impact of Yanling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanling Li more than expected).

Fields of papers citing papers by Yanling Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanling Li. The network helps show where Yanling Li may publish in the future.

Co-authorship network of co-authors of Yanling Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yanling Li. A scholar is included among the top collaborators of Yanling Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanling Li. Yanling Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Jun, Yanling Li, Lihua Chen, et al.. (2025). Six pairs of α-pyrone meroterpenoid dimers from Hypericum monogynum with anti-neuroinflammatory activity. Organic Chemistry Frontiers. 12(5). 1593–1602.
3.
Chen, Wei, Peng Wang, Ronghua Wang, et al.. (2024). Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells. Cell Death and Disease. 15(1). 102–102. 24 indexed citations
4.
Xiao, Chufan, Xiufang Liu, Yuyang Pan, et al.. (2024). Tailored UPRE2 variants for dynamic gene regulation in yeast. Proceedings of the National Academy of Sciences. 121(19). e2315729121–e2315729121. 6 indexed citations
5.
Yang, Li, et al.. (2024). The Antitumor Effects of α-Linolenic Acid. Journal of Personalized Medicine. 14(3). 260–260. 9 indexed citations
6.
Wang, Peng, Yanling Li, Bin Cheng, et al.. (2024). Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma. Computers in Biology and Medicine. 169. 107975–107975. 6 indexed citations
7.
Liu, Siyi, Wentao Li, Lin Liang, Yanhong Zhou, & Yanling Li. (2024). The regulatory relationship between transcription factor STAT3 and noncoding RNA. Cellular & Molecular Biology Letters. 29(1). 4–4. 18 indexed citations
8.
Liu, Haidong, et al.. (2023). QTL analysis and candidate gene prediction for seed density per silique by QTL-seq and RNA-seq in spring Brassica napus L.. PLoS ONE. 18(3). e0281875–e0281875. 1 indexed citations
9.
Wang, Lu, et al.. (2022). The traditional uses, phytochemistry and pharmacology of Abrus precatorius L.: A comprehensive review. Journal of Ethnopharmacology. 296. 115463–115463. 29 indexed citations
10.
Xin, Shuyu, Liu L, Yanling Li, et al.. (2022). Cyclophilin A binds to AKT1 and facilitates the tumorigenicity of Epstein-Barr virus by mediating the activation of AKT/mTOR/NF-κB positive feedback loop. Virologica Sinica. 37(6). 913–921. 6 indexed citations
11.
Wang, Ming, Wenyan Zhang, Yibo Liu, et al.. (2022). PDIA4 promotes glioblastoma progression via the PI3K/AKT/m-TOR pathway. Biochemical and Biophysical Research Communications. 597. 83–90. 17 indexed citations
12.
Zhao, Tingting, Molin Liu, Duo Cao, et al.. (2021). Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update. Frontiers in Pharmacology. 12. 707696–707696. 44 indexed citations
13.
Chen, Zhe, Hai‐Bin Tang, Jun‐Jun Kang, et al.. (2021). Necroptotic astrocytes induced neuronal apoptosis partially through EVs-derived pro-BDNF. Brain Research Bulletin. 177. 73–80. 17 indexed citations
14.
Yang, Liangchun, Fanghua Ye, Li Zeng, Yanling Li, & Wenwen Chai. (2020). <p>Knockdown of HMGB1 Suppresses Hypoxia-Induced Mitochondrial Biogenesis in Pancreatic Cancer Cells</p>. OncoTargets and Therapy. Volume 13. 1187–1198. 9 indexed citations
15.
Xie, Xiaoying, Xiaoqiang Liu, Yanling Li, et al.. (2020). Advanced Glycation End Products Enhance Biofilm Formation by Promoting Extracellular DNA Release Through sigB Upregulation in Staphylococcus aureus. Frontiers in Microbiology. 11. 1479–1479. 23 indexed citations
16.
Liu, Yu, Yanling Li, Sheng Tong, et al.. (2019). Expression of a Beauveria bassiana chitosanase (BbCSN-1) in Pichia pastoris and enzymatic analysis of the recombinant protein. Protein Expression and Purification. 166. 105519–105519. 16 indexed citations
17.
Li, Xiaoming, et al.. (2018). MicroRNA-98-5p ameliorates oxygen-glucose deprivation/reoxygenation (OGD/R)-induced neuronal injury by inhibiting Bach1 and promoting Nrf2/ARE signaling. Biochemical and Biophysical Research Communications. 507(1-4). 114–121. 37 indexed citations
18.
Zhang, Fu, et al.. (2018). Neuropilin 1 ameliorates electrical remodeling at infarct border zones in rats after myocardial infarction. Autonomic Neuroscience. 214. 19–23. 4 indexed citations
19.
Wu, Yanli, Yongdong Feng, Yanling Li, et al.. (2016). Sub-chronic 90-day toxicity of neamine in SD rats and its anti-liver cancer activity in vitro and in vivo. Toxicology and Applied Pharmacology. 315. 50–59. 2 indexed citations
20.
Li, Yanling. (2013). Related cytokines expression level in peripheral blood of patients with diabetes mellitus and autoimmune thyroid disease. Zhonghua linchuang yishi zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026